I am rather surprised at how uninformed many posters are here regarding DNAX. In their December 18, 2014 investor news on the company's website, they made it clear that they had sold a large portion of their inventory at a loss:
As explained by the company previously, DNA's former CEO overextended the company's finances by approving purchase of inventory without sufficient distribution to move it. This left the company with inventory they could not move and little liquid cash. It is now obvious that DNA management unloaded the excess inventory via Big Lots and now have additional cash that was much needed.